Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and fo… Read more
Market Cap & Net Worth: Medartis Holding AG (MDRSF)
Medartis Holding AG (PINK:MDRSF) has a market capitalization of $829.01 Million ($829.01 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #8539 globally and #4274 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medartis Holding AG's stock price $66.68 by its total outstanding shares 12432612 (12.43 Million).
Medartis Holding AG Market Cap History: 2017 to 2025
Medartis Holding AG's market capitalization history from 2017 to 2025. Data shows growth from $497.30K to $829.01 Million (169.34% CAGR).
Medartis Holding AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medartis Holding AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.69x
Medartis Holding AG's market cap is 3.69 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
234.98x
Medartis Holding AG's market cap is 234.98 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $497.30K | $105.04 Million | $866.52K | 0.00x | 0.57x |
| 2019 | $3.73 Million | $130.14 Million | $2.15 Million | 0.03x | 1.74x |
| 2020 | $584.33 Million | $127.65 Million | -$943.57K | 4.58x | N/A |
| 2021 | $733.52 Million | $159.88 Million | $6.84 Million | 4.59x | 107.27x |
| 2022 | $733.52 Million | $182.82 Million | -$5.78 Million | 4.01x | N/A |
| 2023 | $969.25 Million | $212.01 Million | $619.00K | 4.57x | 1565.83x |
| 2024 | $829.01 Million | $224.83 Million | $3.53 Million | 3.69x | 234.98x |
Competitor Companies of MDRSF by Market Capitalization
Companies near Medartis Holding AG in the global market cap rankings as of March 19, 2026.
Key companies related to Medartis Holding AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Medartis Holding AG Historical Marketcap From 2017 to 2025
Between 2017 and today, Medartis Holding AG's market cap moved from $497.30K to $ 829.01 Million, with a yearly change of 169.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $829.01 Million | 0.00% |
| 2024 | $829.01 Million | -14.47% |
| 2023 | $969.25 Million | +32.14% |
| 2022 | $733.52 Million | 0.00% |
| 2021 | $733.52 Million | +25.53% |
| 2020 | $584.33 Million | +15566.67% |
| 2019 | $3.73 Million | +650.00% |
| 2017 | $497.30K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Medartis Holding AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $829.01 Million USD |
| MoneyControl | $829.01 Million USD |
| MarketWatch | $829.01 Million USD |
| marketcap.company | $829.01 Million USD |
| Reuters | $829.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.